澳门凯旋门网上娱乐场

Welcome to the official website of Xi'an Laka Instrument Equipment Co., Ltd.!

News Center

Researchers propose new strategy for nano-catalytic medical tumor treatment

时间: 2017-09-07 11:55:08 来源: 西安拉卡仪器设备有限公司 Share time: 2017-09-07 11:55:08 source: Xi'an Laka Instrument Equipment Co., Ltd.

As a human health killer, cancer has always had a high incidence and mortality rate. Overcoming cancer has always been a difficult problem to be solved. In the current cancer treatment strategy, chemotherapy is one of the most commonly used methods. However, the highly toxic chemotherapy drugs used in conventional cancer chemotherapy have a pharmacological effect on the whole body, causing strong toxic and side effects. The efficacy is greatly reduced. In fact, toxic side effects and multi-cycle chemotherapy bring greater pain to cancer patients, and even become the main cause of death for cancer chemotherapy patients. Therefore, it is particularly important to develop therapeutic strategies that are highly toxic to tumors, highly selective, and non-toxic to normal tissues and organs.

In this work, the research team synthesized a dendritic mesoporous silica nanoparticle as a carrier of a drug delivery system, loaded ultra-small ferric oxide nanoparticles and glucose oxidase in order to construct a chain-catalyzed A new type of nanocatalyst. The glucose oxidase in the nanocatalyst is a highly active organic enzyme, and the ferric oxide nanoparticle is a highly efficient and highly stable Fenton reaction catalyst.

Shi Jianlin told reporters that the catalyst uses the strong glucose raw materials and slightly acidic metabolic environment in tumor cells to perform highly efficient biological enzyme-catalyzed reactions and chemical Fenton-catalyzed reactions in a chain. In the first biological enzyme-catalyzed reaction, glucose oxidase selectively catalyzes d-glucose in the tumor to produce hydrogen peroxide and glucose lactone. Hydrogen peroxide, as a reactant for the next chemical Fenton-catalyzed reaction, is catalyzed by ferric oxide under acidic conditions to generate a highly toxic reactive oxygen species-hydroxyl radical. Highly toxic hydroxyl radicals can induce tumor cell apoptosis, while killing tumor cells without causing damage to normal tissues and organs. The results of in vivo animal experiments show that the nanocatalyst has no adverse effects on healthy mice within 1 month, indicating that it has good biological safety in vivo. In vivo toxicity studies of tumor-bearing mice, it was found that the inhibition efficiency of 4T1 breast cancer tumors and U87 glioma tumors reached 64.67% and 57.24%, respectively, indicating that the nanocatalyst has better tumor killing and inhibiting ability. This work realized that safe and non-toxic nanomedicine catalysts could generate toxic substances in situ under the stimulation of tumor microenvironment to kill tumors, and provided a new nanocatalytic medical strategy for accurate tumor treatment in the future.

It is reported that this research work has received funding and support from the National Key Research and Development Program “Young Scientists” (Nano-Special), the National Natural Science Foundation of China, the Young Talent Project of the Chinese Chemical Society, and the Youth Innovation Promotion Association of the Chinese Academy of Sciences.

relevant information

Home | About Us | News Center | Products Center | Case | Service Center | Message Board | Contact Us

西安拉卡仪器设备有限公司

Copyright: Xi'an Laka Instrument Equipment Co., Ltd. Record number: Shaanxi ICP No. 17002886

Address: 11th Floor, Unit 1, Shaanxi International Convention and Exhibition Building, No. 1 Chang'an North Road, Beilin District, Xi'an, Shaanxi Province

Technical support: China Easy Internet background login
Scan and follow me

Scan and follow me